Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2

Status

Completed 5

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Dermatologic 5

Conditions

Melanoma 2653Lymphoma, T-Cell, Cutaneous 479Skin Neoplasms 408Carcinoma, Non-Small-Cell Lung 377Mycosis Fungoides 330Neoplasms 319Keratosis, Actinic 300Sezary Syndrome 294Breast Neoplasms 285Neoplasm Metastasis 284Carcinoma, Renal Cell 280Lymphoma, Non-Hodgkin 276Lymphoma 264Carcinoma, Basal Cell 263Lymphoma, Large B-Cell, Diffuse 261Leukemia, Lymphocytic, Chronic, B-Cell 261Lymphoma, Follicular 259Hodgkin Disease 247Lymphoma, Mantle-Cell 245Lymphoma, B-Cell, Marginal Zone 245Precursor Cell Lymphoblastic Leukemia-Lymphoma 243Uveal Melanoma 234Burkitt Lymphoma 233Lymphoma, Large-Cell, Immunoblastic 223Colorectal Neoplasms 196Lymphoma, Large-Cell, Anaplastic 190Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 186Ovarian Neoplasms 181Squamous Cell Carcinoma of Head and Neck 180Lung Neoplasms 179

Interventions

3-ingenyl angelate 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Melanosis × Dermatologic × Clear all
NCT04834167 2023-11-30

OneDoc Picopulseâ„¢ for the Treatment of Melasma Among Malaysian Women

Universiti Tunku Abdul Rahman

Phase NA Completed
32 enrolled
Dermatologic

Melanoma, Melanosis, Skin Diseases

NCT01444989 2018-08-15

AKRQ

Wake Forest University Health Sciences

Phase NA Completed
150 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

NCT00375739 2016-01-28

Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses

Peplin

Phase 2 Completed
200 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

NCT00107965 2015-03-25

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses

Peplin

Phase 2 Completed
60 enrolled
Dermatologic

Melanosis, Keratosis, Actinic

NCT00239135 2015-03-25

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Peplin

Phase 2 Completed
34 enrolled
Dermatologic

Keratosis, Melanosis, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡